Skip to main content
Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
3.030
-0.050 (-1.62%)
Nov 11, 2026, 10:14 AM EST - Market open

Whitehawk Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1791147850313505
Market Cap Growth
83.28%46.66%56.96%-84.17%-37.97%-
Enterprise Value
9-4916-68132344
Last Close Price
3.082.423.152.0212.8324.15

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-15.962.992.0320.57450.53
PB Ratio
1.110.841.480.471.983.70
P/TBV Ratio
1.110.841.480.471.983.81

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
--0.62-8.66306.99

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.00-0.020.010.010.00
Net Debt / Equity Ratio
-1.04-1.07-0.88-1.02-1.08-1.09
Net Debt / EBITDA Ratio
1.891.270.721.502.914.01
Net Debt / FCF Ratio
2.301.490.761.693.416.60
Asset Turnover
-0.070.260.150.090.01
Inventory Turnover
--0.5212.49--
Quick Ratio
16.2510.043.114.339.269.76
Current Ratio
16.4710.263.594.729.569.90
Return on Equity (ROE)
-52.01%-21.82%-80.79%-49.90%-41.06%-177.60%
Return on Assets (ROA)
-32.82%-64.66%-39.96%-28.39%-21.54%-26.21%
Return on Capital Employed (ROCE)
-54.80%-83.90%-121.70%-67.80%-35.60%-26.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-34.85%-18.06%-81.90%-132.75%-19.33%-21.82%
FCF Yield
-40.52%-85.91%-78.71%-128.45%-16.00%-4.45%
Buyback Yield / Dilution
-53.67%-128.96%-0.42%-19.58%-152.27%-250.99%